WuXi XDC Cayman HK$3.68 billion IPO
The shares are listed on the HKEX
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Bristol Myers Squibb $4.5 billion notes offering
The investment-grade offering comprised four tranches
Alector $125 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
NeuroPace $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Aligos Therapeutics $92 million private placement
The PIPE included common stock and warrants
Roivant Sciences registered direct offering and investment in Immunovant
We advised Roivant on the transactions
Inventiva $58 million at-the-market offering
The American depositary shares are listed on Nasdaq
HilleVax $115 million follow-on offering
The shares are listed on the Nasdaq Global Select Market